Unable to load price data. Sorry.


Northfield Laboratories (NASDAQOTH:NFLDQ.DL.P)

CAPS Rating: No stars

The Company researchs, develops, tests, manufactures, markets and distributes a hemoglobin-based blood substitute product.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQOTH:NFLDQ.DL.P Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Godzilla110 (30.37)
Submitted January 17, 2007

Based on their burn rate, they should be out of cash and equivalents in about 2 years. I believe this is sufficient time for the company to improve the product enough to receive FDA approval. I'm taking this position based on the presidents letter to… More

NetscribeBiotech (92.19)
Submitted January 03, 2007

Northfield Laboratories is a development stage company engages in the research, development, testing, manufacture, marketing, and distribution of hemoglobin-based blood substitute products. Its primary investigational drug PolyHeme is a human… More



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about NFLDQ.DL.P.

No one has written a Pitch for NFLDQ.DL.P stock yet. Tell us why you think NFLDQ.DL.P will outperform or underperform against the market.


Find the members with the highest scoring picks in NFLDQ.DL.P.

No players have picked NFLDQ.DL.P yet. Tell us why you think NFLDQ.DL.P will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NFLDQ.DL.P.